Fehniger TA, Watkins MP, Ezenwajiaku N, Wan F, Hurd DD, Cashen AF, Blum KA, Goy A, Fenske TS, Wagner-Johnston ND, Carson K, Siegel MJ, Russler-Germain D, Schneider SE, Mehta-Shah N, Kahl B, Bartlett NL. A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma. haematol [Internet]. 2024Mar.1 [cited 2024May8];109(3):953-7. Available from: https://haematologica.org/article/view/haematol.2022.282246